vs
DT Midstream, Inc.（DTM）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
DT Midstream, Inc.的季度营收约是Orthofix Medical Inc.的1.4倍（$317.0M vs $219.9M），DT Midstream, Inc.净利率更高（35.0% vs -1.0%，领先36.0%），DT Midstream, Inc.同比增速更快（27.3% vs 2.0%），DT Midstream, Inc.自由现金流更多（$30.0M vs $16.8M），过去两年DT Midstream, Inc.的营收复合增速更高（14.9% vs 8.0%）
ONEOK是美国油气中游运营商，总部位于俄克拉荷马州塔尔萨，为油气行业提供收集、处理、分馏、运输及存储服务，是财富500强企业及标普500指数成分股。公司1906年成立时名为俄克拉荷马天然气公司，1980年更为现名。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DTM vs OFIX — 直观对比
营收规模更大
DTM
是对方的1.4倍
$219.9M
营收增速更快
DTM
高出25.3%
2.0%
净利率更高
DTM
高出36.0%
-1.0%
自由现金流更多
DTM
多$13.2M
$16.8M
两年增速更快
DTM
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $317.0M | $219.9M |
| 净利润 | $111.0M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 49.2% | 0.2% |
| 净利率 | 35.0% | -1.0% |
| 营收同比 | 27.3% | 2.0% |
| 净利润同比 | 52.1% | 92.4% |
| 每股收益（稀释后） | $1.07 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DTMOFIX
| Q4 25 | $317.0M | $219.9M | ||
| Q3 25 | $314.0M | $205.6M | ||
| Q2 25 | $309.0M | $203.1M | ||
| Q1 25 | $303.0M | $193.6M | ||
| Q4 24 | $249.0M | $215.7M | ||
| Q3 24 | $248.0M | $196.6M | ||
| Q2 24 | $244.0M | $198.6M | ||
| Q1 24 | $240.0M | $188.6M |
净利润DTMOFIX
| Q4 25 | $111.0M | $-2.2M | ||
| Q3 25 | $115.0M | $-22.8M | ||
| Q2 25 | $107.0M | $-14.1M | ||
| Q1 25 | $108.0M | $-53.1M | ||
| Q4 24 | $73.0M | $-29.1M | ||
| Q3 24 | $88.0M | $-27.4M | ||
| Q2 24 | $96.0M | $-33.4M | ||
| Q1 24 | $97.0M | $-36.0M |
毛利率DTMOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率DTMOFIX
| Q4 25 | 49.2% | 0.2% | ||
| Q3 25 | 49.4% | -8.3% | ||
| Q2 25 | 50.2% | -7.9% | ||
| Q1 25 | 48.8% | -25.2% | ||
| Q4 24 | 45.4% | -5.3% | ||
| Q3 24 | 49.2% | -9.6% | ||
| Q2 24 | 53.3% | -12.5% | ||
| Q1 24 | 51.7% | -15.6% |
净利率DTMOFIX
| Q4 25 | 35.0% | -1.0% | ||
| Q3 25 | 36.6% | -11.1% | ||
| Q2 25 | 34.6% | -6.9% | ||
| Q1 25 | 35.6% | -27.4% | ||
| Q4 24 | 29.3% | -13.5% | ||
| Q3 24 | 35.5% | -13.9% | ||
| Q2 24 | 39.3% | -16.8% | ||
| Q1 24 | 40.4% | -19.1% |
每股收益（稀释后）DTMOFIX
| Q4 25 | $1.07 | $-0.05 | ||
| Q3 25 | $1.13 | $-0.57 | ||
| Q2 25 | $1.04 | $-0.36 | ||
| Q1 25 | $1.06 | $-1.35 | ||
| Q4 24 | $0.73 | $-0.76 | ||
| Q3 24 | $0.90 | $-0.71 | ||
| Q2 24 | $0.98 | $-0.88 | ||
| Q1 24 | $0.99 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.0M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.7B | $450.0M |
| 总资产 | $10.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DTMOFIX
| Q4 25 | $54.0M | $82.0M | ||
| Q3 25 | $98.0M | $62.9M | ||
| Q2 25 | $74.0M | $65.6M | ||
| Q1 25 | $83.0M | $58.0M | ||
| Q4 24 | $68.0M | $83.2M | ||
| Q3 24 | $77.0M | $30.1M | ||
| Q2 24 | $73.0M | $26.4M | ||
| Q1 24 | $41.0M | $27.0M |
总债务DTMOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | $3.4B | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益DTMOFIX
| Q4 25 | $4.7B | $450.0M | ||
| Q3 25 | $4.7B | $442.5M | ||
| Q2 25 | $4.7B | $458.3M | ||
| Q1 25 | $4.6B | $458.3M | ||
| Q4 24 | $4.6B | $503.1M | ||
| Q3 24 | $4.2B | $525.9M | ||
| Q2 24 | $4.2B | $546.0M | ||
| Q1 24 | $4.2B | $570.3M |
总资产DTMOFIX
| Q4 25 | $10.1B | $850.6M | ||
| Q3 25 | $10.1B | $832.6M | ||
| Q2 25 | $10.0B | $837.2M | ||
| Q1 25 | $9.9B | $823.1M | ||
| Q4 24 | $9.9B | $893.3M | ||
| Q3 24 | $8.6B | $867.9M | ||
| Q2 24 | $9.0B | $882.0M | ||
| Q1 24 | $9.0B | $906.0M |
负债/权益比DTMOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | 0.72× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $161.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $30.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 9.5% | 7.6% |
| 资本支出强度资本支出/营收 | 41.3% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.45× | — |
| 过去12个月自由现金流最近4个季度 | $441.0M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DTMOFIX
| Q4 25 | $161.0M | $27.7M | ||
| Q3 25 | $274.0M | $12.4M | ||
| Q2 25 | $185.0M | $11.6M | ||
| Q1 25 | $247.0M | $-18.4M | ||
| Q4 24 | $152.0M | $23.7M | ||
| Q3 24 | $205.0M | $11.7M | ||
| Q2 24 | $165.0M | $9.0M | ||
| Q1 24 | $241.0M | $-18.6M |
自由现金流DTMOFIX
| Q4 25 | $30.0M | $16.8M | ||
| Q3 25 | $131.0M | $2.5M | ||
| Q2 25 | $104.0M | $4.5M | ||
| Q1 25 | $176.0M | $-25.1M | ||
| Q4 24 | $62.0M | $15.2M | ||
| Q3 24 | $124.0M | $6.3M | ||
| Q2 24 | $84.0M | $-360.0K | ||
| Q1 24 | $143.0M | $-29.1M |
自由现金流率DTMOFIX
| Q4 25 | 9.5% | 7.6% | ||
| Q3 25 | 41.7% | 1.2% | ||
| Q2 25 | 33.7% | 2.2% | ||
| Q1 25 | 58.1% | -13.0% | ||
| Q4 24 | 24.9% | 7.0% | ||
| Q3 24 | 50.0% | 3.2% | ||
| Q2 24 | 34.4% | -0.2% | ||
| Q1 24 | 59.6% | -15.4% |
资本支出强度DTMOFIX
| Q4 25 | 41.3% | 4.9% | ||
| Q3 25 | 45.5% | 4.8% | ||
| Q2 25 | 26.2% | 3.5% | ||
| Q1 25 | 23.4% | 3.5% | ||
| Q4 24 | 36.1% | 4.0% | ||
| Q3 24 | 32.7% | 2.7% | ||
| Q2 24 | 33.2% | 4.7% | ||
| Q1 24 | 40.8% | 5.6% |
现金转化率DTMOFIX
| Q4 25 | 1.45× | — | ||
| Q3 25 | 2.38× | — | ||
| Q2 25 | 1.73× | — | ||
| Q1 25 | 2.29× | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 1.72× | — | ||
| Q1 24 | 2.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DTM
| Pipeline Segment | $173.0M | 55% |
| Gathering Segment | $144.0M | 45% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
